Another study showed that in HNSCC cells, co-inhibition of MEK and FGFR3 activity reduced AKT and ERKs phosphorylation, which in turn led to increased DNA fragmentation, caspase 3 cleavage, and reduced tumor growth in vivo [118]. The gene discussed is FGFR3; the disease is neoplasm.